Patents Assigned to Guangdong Longsee Biomedical Co. Ltd.
  • Publication number: 20220110314
    Abstract: A nucleic acid preservation solution, a preparation method and application for same is disclosed. The nucleic acid preservation solution of the invention includes, by weight percentage, citric acid 13%-35%, Tween 20 0.50%-2.50%, disodium ethylene diamine tetraacetic acid (EDTA) 13%-40%, sodium sulfate 35%-70%, polyethylene glycol octyl phenyl ether 0.50%-2.50%, and the balance being diethylpyrocarbonate (DEPC) water.
    Type: Application
    Filed: November 26, 2020
    Publication date: April 14, 2022
    Applicants: Guangdong Longsee Biomedical Co. LTD., Foshan Langsee Biotechnology Co. LTD.
    Inventors: Zhao Zhang, Jiayin Diao, Yan Ma, Kangdi Zheng, Tao Chen
  • Publication number: 20220016187
    Abstract: A strain of Lactobacillus paracasei L.p R3-10 and its application in preparation of medicine for treating ulcerative colitis are disclosed. The Lactobacillus paracasei R3-10 of the present disclosure is a Lactobacillus induced by a low nutritional gradient tolerance, it is obtained after L.p R3 has been domesticated by starvation for 10 generations, and its preservation number is CGMCC No. 19520. The L.p R3-10 of the present disclosure can be prepared as a medicine for treating ulcerative colitis.
    Type: Application
    Filed: December 22, 2020
    Publication date: January 20, 2022
    Applicants: Foshan Langsee Biotechnology Co. Ltd., Guangdong Longsee Biomedical Co. Ltd.
    Inventors: Jincheng ZENG, Juan HUANG, Weiqing YANG, Zhao ZHANG, Ziyan YANG, Bihua LIN, Tao CHEN, Chunyan LEI
  • Patent number: D1004125
    Type: Grant
    Filed: November 16, 2021
    Date of Patent: November 7, 2023
    Assignees: GUANGDONG LONGSEE BIOMEDICAL CO., LTD., FOSHAN LONGSEE BIOMEDICAL CO., LTD.
    Inventors: Tao Chen, Zhao Zhang, Shizhou Deng, Fengxi Yu